Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 2 1Phase 1/2 1

Status

Unknown 4Active not recruiting 2

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4Lymphoid 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Recurrence 13Multiple Myeloma 12Lymphoma, B-Cell 12Lymphoma, Non-Hodgkin 8Leukemia, Lymphocytic, Chronic, B-Cell 8Ovarian Neoplasms 7Burkitt Lymphoma 7Lymphoma 6Lymphoma, Mantle-Cell 5Hematologic Neoplasms 5Nasopharyngeal Carcinoma 4Myelodysplastic Syndromes 4Melanoma 4Lymphoma, T-Cell 4Leukemia 3Graft vs Host Disease 3Uterine Cervical Neoplasms 2Sarcoma, Synovial 2Neuroblastoma 2Neoplasms, Plasma Cell 2Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, T-Cell 2Hodgkin Disease 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Cisplatin 51Gemcitabine 24Radiotherapy, Intensity-Modulated 20Docetaxel 20Fluorouracil 15camrelizumab 12Drug Therapy 11Radiotherapy 10toripalimab 8Chemoradiotherapy 8Capecitabine 8apatinib 7Induction Chemotherapy 7nimotuzumab 6endostar protein 6Endostatins 6sintilimab 5nedaplatin 5Bevacizumab 5fludarabine 4Cyclophosphamide 4spartalizumab 3fludarabine phosphate 3cisplatin-guanosine adduct 3SSRP1 protein, human 3Paclitaxel 3Injections 3Endoscopy 3tislelizumab 2Vitamin B 12 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Nasopharyngeal Carcinoma × fludarabine × Clear all
NCT05654077 2022-12-19

EBV CAR-T Cells for Nasopharyngeal Carcinoma

The Affiliated Hospital of Xuzhou Medical University

Phase EARLY_PHASE1 Unknown
24 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05616468 2022-12-15

BGT007 Cell Treatment of Nasopharyngeal Carcinoma

The Affiliated Hospital of Xuzhou Medical University

Phase EARLY_PHASE1 Unknown
23 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT03648697 2020-08-11

EBV-TCR-T(YT-E001)for Patients With EBV-positive Recurrent or Metastatic NPC

Fujian Cancer Hospital

Phase 2 Unknown
20 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT03044743 2017-05-02

PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 1/2 Unknown
20 enrolled
GastrointestinalHead & NeckLymphoid

Nasopharyngeal Carcinoma, Hodgkin Disease, Stomach Neoplasms, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡